These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16768122)

  • 21. [Diagnosis and therapy in NASH].
    Tokushige K
    Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease of obesity.
    Sachdev MS; Riely CA; Madan AK
    Obes Surg; 2006 Nov; 16(11):1412-9. PubMed ID: 17132404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pediatric nonalcoholic fatty liver disease/nonalcoholic steatohepatitis].
    Takahashi Y; Fukusato T; Inui A; Fujisawa T
    Nihon Rinsho; 2012 Oct; 70(10):1827-34. PubMed ID: 23198569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic steatohepatitis.
    Das K; Kar P
    J Assoc Physicians India; 2005 Mar; 53():195-9. PubMed ID: 15926603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease.
    Choudhury J; Sanyal AJ
    Clin Liver Dis; 2004 Aug; 8(3):575-94, ix. PubMed ID: 15331065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pediatric non-alcoholic fatty liver disease: recent advances and challenges].
    Poggiogalle E; Olivero G; Anania C; Ferraro F; Pacifico L
    Minerva Pediatr; 2010 Dec; 62(6):569-84. PubMed ID: 21042270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J; Torok N
    Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic steatohepatitis.
    Brunt EM
    Semin Liver Dis; 2004 Feb; 24(1):3-20. PubMed ID: 15085483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging problem of nonalcoholic steatohepatitis (NASH).
    Portincasa P; Grattagliano I; Palmieri VO; Palasciano G
    Rom J Gastroenterol; 2005 Mar; 14(1):43-51. PubMed ID: 15800693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [NASH in children].
    Ida S; Yoshimura N
    Nihon Rinsho; 2006 Jun; 64(6):1168-72. PubMed ID: 16768127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Widhalm K; Ghods E
    Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.
    Barshop NJ; Sirlin CB; Schwimmer JB; Lavine JE
    Aliment Pharmacol Ther; 2008 Jul; 28(1):13-24. PubMed ID: 18397387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Non-alcoholic fatty liver].
    Tagle Arrospide M
    Rev Gastroenterol Peru; 2003; 23(1):49-57. PubMed ID: 12768215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.
    Kang H; Greenson JK; Omo JT; Chao C; Peterman D; Anderson L; Foess-Wood L; Sherbondy MA; Conjeevaram HS
    Am J Gastroenterol; 2006 Oct; 101(10):2247-53. PubMed ID: 17032189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease.
    Adams LA; Lindor KD
    Ann Epidemiol; 2007 Nov; 17(11):863-9. PubMed ID: 17728149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.